GSK’s Generic Flonase Antitrust Deal Gets Green Light

A Pennsylvania federal judge approved a settlement between GlaxoSmithKline and two groups of plaintiffs in an antitrust class action accusing the pharmaceutical giant of improperly blocking rivals from bringing generic versions of allergy medication Flonase (fluticasone) to market.
Law360